<SEC-DOCUMENT>0000731766-21-000033.txt : 20210715
<SEC-HEADER>0000731766-21-000033.hdr.sgml : 20210715
<ACCEPTANCE-DATETIME>20210715060356
ACCESSION NUMBER:		0000731766-21-000033
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20210715
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210715
DATE AS OF CHANGE:		20210715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		211091607

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>unh-20210715.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4b19fdab-f95f-4521-85dc-fc4bc326b269,g:ed81b1ed-4f91-4750-a30e-6fd6374fcf32,d:bf92662661ad431cb03cbc58804cdbc2--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>unh-20210715</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl80L2ZyYWc6OWJiZTJhMWY2Y2ZlNGMyMmE3MGFjNTVjMzZiMTJmMTYvdGFibGU6YTI5OTRjMDIxOWUwNGNiYjkwOGZmMWI1ZDMxZDgwZDQvdGFibGVyYW5nZTphMjk5NGMwMjE5ZTA0Y2JiOTA4ZmYxYjVkMzFkODBkNF8yLTEtMS0xLTA_d33128df-4933-4bbd-b098-20a13afafa04">0000731766</ix:nonNumeric><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl80L2ZyYWc6OWJiZTJhMWY2Y2ZlNGMyMmE3MGFjNTVjMzZiMTJmMTYvdGFibGU6YTI5OTRjMDIxOWUwNGNiYjkwOGZmMWI1ZDMxZDgwZDQvdGFibGVyYW5nZTphMjk5NGMwMjE5ZTA0Y2JiOTA4ZmYxYjVkMzFkODBkNF8zLTEtMS0xLTA_22b60b04-8a99-40d7-9a44-a8695d1ff03c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="unh-20210715.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-15</xbrli:startDate><xbrli:endDate>2021-07-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibf92662661ad431cb03cbc58804cdbc2_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjkw_4821a4b9-9b32-4ff7-a679-5bfdf5bd68ec">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Current Report </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8yNTc_5387ed7c-75bf-4418-ae5b-d3c1382d6fe9">July 15, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjkx_a2123d33-9f64-46e4-a953-8861d5294a8f">UNITEDHEALTH GROUP INCORPORATED</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:15.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTAtMS0xLTA_3ccd6147-4483-4583-b4ef-42f3b5289f7a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTItMS0xLTA_baba399b-4771-446f-9cd0-9266207fdbd8">1-10864</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTQtMS0xLTA_2fcfb111-a20c-45ee-a48e-24cdc39a3b98">41-1321939</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission File Number)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:59.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTAtMS0xLTA_716864a6-3515-4af4-863f-dcc8ab948ee3">UnitedHealth Group Center, 9900 Bren Road East,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTEtMS0xLTA_3f174e48-fc80-4e35-b063-35281af40d93">Minnetonka,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTItMS0xLTA_caac745f-c73f-4513-baaa-a0df6050f656">Minnesota</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTMtMS0xLTA_55ea7bb1-d5c7-4a7f-aaaf-715bc3ce7d46">55343</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjky_e6460718-bd3f-47ee-9f63-208b5e2bc4a1">952</ix:nonNumeric>) <ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg0_0ab30729-a297-4a57-9a92-cb46660f1277">936-1300</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg1_48aa3e0e-5ee0-4c93-aa94-fb6880662e9a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg2_d9a7603b-bfd2-47db-9d37-02959815e74d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg3_e999fed9-eb75-480a-9a83-a6c74b66f741">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg4_da48ba91-f295-45cf-847b-32387c550ce6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:33.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTAtMS0xLTA_0008709e-4f1b-42a9-a50d-63cbcd3061c7">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTItMS0xLTA_90c7803e-4063-4367-bebe-7f605f4747c1">UNH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTQtMS0xLTA_78e4b9ba-fa40-4b6d-8aec-8a6fb02070e1">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg5_926119c9-9cf8-4f2b-a29b-03b3f4350f85">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ibf92662661ad431cb03cbc58804cdbc2_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 15, 2021, UnitedHealth Group Incorporated (the &#8220;Company&#8221;) issued a press release announcing its second quarter 2021 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q2exhibit991.htm">99.1</a></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q2exhibit991.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q2exhibit991.htm">Ju</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q2exhibit991.htm">ly</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q2exhibit991.htm"> 15, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: July 15, 2021 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Dannette L. Smith</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dannette L. Smith</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secretary to the Board of Directors</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a2021q2exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie3770e1c8ec84f4a87e3d53fd9a3d70e_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">N E W S   R E L E A S E</font></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="uhglogo1a02a01a01a01a42a.jpg" src="uhglogo1a02a01a01a01a42a.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:253px"></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(For Immediate Release)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">UNITEDHEALTH GROUP REPORTS SECOND QUARTER 2021 RESULTS</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Revenues of $71.3 Billion Grew 15%, with Well-Diversified Growth at Optum and UnitedHealthcare</font></div><div style="padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.5pt">Earnings from Operations were $6.0 Billion</font></div><div style="padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.5pt">Cash Flows from Operations reached $5.5 Billion or 1.3x Net Income</font></div><div style="padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.5pt">Net Earnings were $4.46 Per Share and Adjusted Earnings were $4.70 Per Share </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">MINNETONKA, Minn. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">(July 15, 2021) &#8211; Strong and diversified growth continued across UnitedHealth Group (NYSE&#58; UNH) in the second quarter 2021. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8220;The compassion, dedication and ongoing efforts of our 330,000 colleagues to advance peoples&#8217; health and health system performance reinforces our confidence in delivering strongly on our strategies for those we serve and continuing to grow well into the future,&#8221; said Andrew Witty, chief executive officer of UnitedHealth Group.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Based upon first half 2021 performance, the Company increased its full year net earnings outlook to $17.35 to $17.85 per share and adjusted earnings to $18.30 to $18.80 per share. The outlook continues to include approximately $1.80 per share in potential net unfavorable COVID-19 effects.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">UnitedHealth Group is focused on helping people access the care they need, including vaccinations, and expects a continued rise in provision of care in the second half of this year.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">COVID-19 effects include testing and treatment costs&#59; the residual impact of people having deferred care in 2020&#59; and unemployment and other economy-driven factors.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 1 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="uhglogo1a02a01a01a01a42a.jpg" src="uhglogo1a02a01a01a01a42a.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:304px"></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:330.75pt"><tr><td style="width:1.0pt"></td><td style="width:117.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71.3 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62.1 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.2 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.0 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.2 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.7 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">UnitedHealth Group&#8217;s second quarter 2021 revenues of $71.3 billion grew 14.8% year-over-year, reflecting well-diversified growth across the enterprise, including double-digit percentage growth at both Optum and UnitedHealthcare. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Earnings from operations in the second quarter 2021 were $6.0 billion and adjusted earnings were $4.70 per share, with the year-over-year comparisons reflecting the broad-based deferral of care during the second quarter 2020 due to the pandemic. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Cash flows from operations in second quarter 2021 were $5.5 billion, or 1.3 times net income.</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">The second quarter 2021 medical care ratio of 82.8% compared to 70.2% last year, with the variance due to second quarter 2020 COVID-19 effects. Favorable medical reserve development was $500 million in the quarter compared to $1.0 billion in the first quarter 2021 and $1.4 billion in the second quarter last year. Days claims payable of 49.1 days compared to 49.8 days in the first quarter 2021 and 50.4 days in the second quarter 2020.</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">The second quarter 2021 operating cost ratio of 14.5% decreased from 16.1% in second quarter 2020. Factors contributing to the decline include the repeal of the health insurance tax, broad-based 2020 investments to support people and health systems, the revenue-related effects of the pandemic, and continued productivity advances, partially offset by business mix and investments. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">The Company returned $1.4 billion to shareholders in the second quarter via dividends, following a 16% increase in June 2021. In the quarter, 3.2 million shares were repurchased for $1.2 billion, bringing year-to-date repurchases to 7.9 million shares for $2.9 billion.  </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Return on equity of 25.2% in the quarter reflected the Company&#8217;s strong and diverse earnings profile and efficient capital base. Debt to total capital was 40.1% at quarter end.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="uhclogoa02a01a01a01a37a.jpg" src="uhclogoa02a01a01a01a37a.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:293px"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries.  UnitedHealthcare is dedicated to improving the value customers and consumers receive by reducing the total cost of care, enhancing the quality of care received, improving health and wellness and simplifying the health care experience.</font></div><div style="margin-bottom:1pt;margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:348.75pt"><tr><td style="width:1.0pt"></td><td style="width:118.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55.5 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$49.1 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55.1 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.1 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.0 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.1 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">UnitedHealthcare second quarter 2021 revenues grew by $6.4 billion or 13.0% to $55.5 billion compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">last year. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">Strong growth in UnitedHealthcare&#8217;s community and senior offerings resulted from expansion in people served. Since the end of 2020, total people served by UnitedHealthcare grew by nearly 1.2 million, including 150,000 in the second quarter 2021. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">Second quarter 2021 operating earnings were $3.1 billion compared to $7.0 billion last year, reflecting strong revenue growth, more than offset by pandemic driven deferral of care last year.</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">Growth highlights include&#58; continued strong membership growth during the first half this year in individual Medicare Advantage, Group Medicare Advantage and Dual Special Needs Plans&#59; Medicaid contract awards in Hawaii and Ohio, as well as a strong pipeline of potential new and renewing awards during the remainder of 2021&#59; and further expansion of innovative commercial benefit products and capabilities such as our care provider-aligned and consumer-centric products, and continued outlook for strong specialty benefits growth.  </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 3 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="optumblacka30a.jpg" src="optumblacka30a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:252px"></div><div><font><br></font></div><div style="margin-bottom:15pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Optum is a health services business serving the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers.  Using market-leading information, data analytics, technology and clinical insights, Optum helps improve overall health system performance&#58; optimizing care quality, reducing health care costs and improving the consumer experience.</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:342.75pt"><tr><td style="width:1.0pt"></td><td style="width:112.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$38.3 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.7 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.4 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.2 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.6 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">Optum second quarter revenues of $38.3 billion grew 17.2% and operating earnings of $2.9 billion grew 29.1%, with each of the three Optum businesses contributing double-digit operating earnings growth. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">OptumHealth served 99 million people at the end of second quarter 2021 compared to 97 million a year ago, and revenue per consumer served increased 43% year-over-year. This continues the expansion of people served in value-based care arrangements, growth in affiliated physicians and build-out of local market care delivery services including in-home, clinic-based and outpatient services, all on a multi-payer basis. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">OptumInsight&#8217;s revenue backlog increased by $1.9 billion or 10% compared to the second quarter 2020 to $21.3 billion, driven by growth in comprehensive managed services. OptumInsight continues to advance initiatives to help health systems scale essential capabilities through the deployment of advanced technology, innovative talent and labor models and progressive approaches to productivity enhancements. This includes a significant new client relationship with Bassett Healthcare Network to help them improve clinical and operational performance. </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">OptumRx adjusted scripts in the quarter were 342 million, growth of 8% compared to last year and 4% from the first quarter 2021, as the provision of care has continued to recover over the last year. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">    </font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:13.8pt">Growth highlights include&#58; continued expansion of Optum Care&#8217;s integrated care delivery networks and growth serving people in their homes&#59; OptumInsight new business wins and continued pipeline expansion in comprehensive managed services, including revenue management, information technology, data analytics and payment integrity&#59; and OptumRx&#8217;s continued diversification and growth of pharmacy care services, highlighted by specialty pharmacy, infusion services, community-based behavioral health pharmacies and e-commerce. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 4 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">About UnitedHealth Group</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">UnitedHealth Group (NYSE&#58; UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms&#58; Optum, which provides information and technology-enabled health services&#59; and UnitedHealthcare, which provides health care coverage and benefits services. For more information, visit UnitedHealth Group at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> or follow &#64;UnitedHealthGrp on Twitter.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Earnings Conference Call</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">As previously announced, UnitedHealth Group will discuss the company&#8217;s results, strategy and future outlook on a conference call with investors at 8&#58;45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company&#8217;s website (</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">). Following the call, a webcast replay will be available on the same site through July 29, 2021. The conference call replay can also be accessed by dialing 1-888-203-1112, Conference Code&#58; 6765563. This earnings release and the Form 8-K dated July 15, 2021 can also be accessed from the Investor Relations page of the Company&#8217;s website.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Non-GAAP Financial Information</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">The statements, estimates, projections, guidance or outlook contained in this document include &#8220;forward-looking&#8221; statements which are intended to take advantage of the &#8220;safe harbor&#8221; provisions of the federal securities law. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including&#58; risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic&#59; our ability to effectively estimate, price for and manage medical costs&#59; new or changes in existing health care laws or regulations, or their enforcement or application&#59; the DOJ&#8217;s legal action relating to the risk adjustment submission matter&#59; our ability to maintain and achieve improvement in quality scores impacting revenue&#59; reductions in revenue or delays to cash flows received under government programs&#59; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits&#59; failure to maintain effective and efficient information systems or if our technology products do not operate as intended&#59; cyberattacks, other privacy&#47;data security incidents, or our failure to comply with related regulations&#59; risks and uncertainties associated with the pharmacy benefits management industry&#59; competitive pressures&#59; changes in or challenges to our public sector contract awards&#59; our ability to contract on competitive terms with physicians, hospitals and other service providers&#59; failure to attract, develop, retain, and manage the succession of key employees and </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 5 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">executives&#59; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations)&#59; failure to achieve targeted operating cost productivity improvements&#59; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews&#59; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions&#59; fluctuations in foreign currency exchange rates&#59; downgrades in our credit ratings&#59; our investment portfolio performance&#59; impairment of our goodwill and intangible assets&#59; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># # #</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brett Manderfeld</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matt Stearns</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952-936-7216</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202-276-0085</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 6 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="ie3770e1c8ec84f4a87e3d53fd9a3d70e_4"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Earnings Release Schedules and Supplementary Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Quarter Ended June&#160;30, 2021</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Operations</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Balance Sheets</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Cash Flows</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Businesses</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Business Metrics</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Reconciliation of Non-GAAP Financial Measure</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ie3770e1c8ec84f4a87e3d53fd9a3d70e_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended <br>June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56,233</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$49,394</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$111,719</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100,034</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,433</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,247</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,773</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,678</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,099</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,017</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,141</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,321</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,138</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,517</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,559</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,546</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,678</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,450</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,678</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,359</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,582</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,016</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,660</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,501</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,232</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,188</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,343</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,897</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,800</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,322</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,241</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,717</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,237</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(430)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,568</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,811</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,910</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,115)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,560)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,209)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,372</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,350</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,266</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,637</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,128</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share attributable to UnitedHealth Group common shareholders </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.46</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.91</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.55</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.43</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.70</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.02</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.84</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">See page 6 for a reconciliation of the non-GAAP measure</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">June 30,<br>2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br>2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash and short-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$22,561</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$19,781</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,587</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,870</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,768</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,067</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58,916</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53,718</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44,061</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41,242</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">107,315</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102,329</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$210,292</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$197,289</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Medical costs payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$25,131</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$21,872</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,868</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,819</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47,558</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">45,729</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76,557</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72,420</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44,348</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38,648</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,066</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,682</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,299</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,211</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72,022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68,328</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$210,292</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$197,289</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended <br>June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,350</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,161</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in operating assets and liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,545</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,946</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Purchases of investments, net of sales and maturities) Sales and maturities, net of purchases</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,789)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(920)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,642)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,952)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,209)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,485)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,900)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in short-term borrowings and long-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,215</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,342</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,921</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,985</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,832</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,327</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except percentages)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended <br>June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,474</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$49,107</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$110,588</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100,175</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,303</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,695</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,687</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,534</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,456)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,664)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,758)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,150)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71,321</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62,138</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$141,517</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$126,559</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,095</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,007</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,203</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,895</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum (a)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,342</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated earnings from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,978</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,241</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,717</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,237</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating margin</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,942</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,963</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,574</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27,243</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Medicare &#38; Retirement</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,304</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,855</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,778</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,007</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community &#38; State</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,110</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,523</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,083</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,976</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,118</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,300</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,139</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,703</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,331</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,809</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,524</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,371</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,128</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,928</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum eliminations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(478)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(851)</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Earnings from operations for Optum for the three and six months ended June 30, 2021 included $1,128 and $2,090 for OptumHealth&#59; $762 and $1,541 for OptumInsight&#59; and $993 and $1,883 for OptumRx, respectively. Earnings from operations for Optum for the three and six months ended June 30, 2020 included $841 and $1,553 for OptumHealth&#59; $561 and $1,097 for OptumInsight&#59; and $832 and $1,692 for OptumRx, respectively.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTHCARE CUSTOMER PROFILE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in thousands)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.784%"><tr><td style="width:1.0%"></td><td style="width:37.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">People Served</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,840&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,860&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-based</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,455&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,310&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,705&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total Commercial</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,235&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,315&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,220&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,770&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,385&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,605&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,130&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,620&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement (Standardized)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total Community and Senior</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,905&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,700&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,790&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,265&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Domestic Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,140&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,015&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,035&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,485&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,365&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,625&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,475&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,435&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,400&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Medicare Part D stand-alone</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,795&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,120&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTUM PERFORMANCE METRICS</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.631%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Consumers Served (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight Contract Backlog (in billions)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.2</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.4</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Quarterly Adjusted Scripts (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note&#58; UnitedHealth Group served 146 million unique individuals across all businesses at June 30, 2021.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECONCILIATION OF NON-GAAP FINANCIAL MEASURE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADJUSTED NET EARNINGS PER SHARE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.211%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.211%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.211%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.211%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended <br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected <br>Year Ended <br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,266</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,637</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,128</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,019</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16,550 - $17,050</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;1,190</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of intangible amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;(290)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,496</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,839</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,581</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,421</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17,450 - $17,950</font></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted earnings per share</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.46</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.91</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.55</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.43</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.35 - $17.85</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;1.25</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect per share of intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.14)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;(0.30)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted diluted earnings per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.70</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.12</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.02</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.84</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.30 - $18.80</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company&#8217;s acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company&#8217;s revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>unh-20210715.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4b19fdab-f95f-4521-85dc-fc4bc326b269,g:ed81b1ed-4f91-4750-a30e-6fd6374fcf32-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:unh="http://www.unitedhealthgroup.com/20210715" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.unitedhealthgroup.com/20210715">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20210715_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20210715_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20210715_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.unitedhealthgroup.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>unh-20210715_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4b19fdab-f95f-4521-85dc-fc4bc326b269,g:ed81b1ed-4f91-4750-a30e-6fd6374fcf32-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20210715.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended" id="i92a54d639ac94298a2d1e4c14c8134ce_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e25f4061-14c9-4762-b1c5-0ab400c4ec70" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_DocumentType_e25f4061-14c9-4762-b1c5-0ab400c4ec70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_005fb947-b64d-475a-89f9-6148f45b07de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_DocumentPeriodEndDate_005fb947-b64d-475a-89f9-6148f45b07de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_71387310-d232-48a8-a2c7-783b89af99a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityRegistrantName_71387310-d232-48a8-a2c7-783b89af99a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_01e4af33-a396-4310-9dc6-d93c6ee7b710" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityIncorporationStateCountryCode_01e4af33-a396-4310-9dc6-d93c6ee7b710" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c7f0e4b6-9b02-4e9c-8761-a622c85f89af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityFileNumber_c7f0e4b6-9b02-4e9c-8761-a622c85f89af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8bf5c78b-2ed8-4d89-9430-60edf68df8ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityTaxIdentificationNumber_8bf5c78b-2ed8-4d89-9430-60edf68df8ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f8491496-57d3-429f-bfcc-46de3f1129d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressAddressLine1_f8491496-57d3-429f-bfcc-46de3f1129d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0e410715-0f04-4540-971f-55025a149ac6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressCityOrTown_0e410715-0f04-4540-971f-55025a149ac6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_427c72b0-361b-459f-8a77-deda66fa3aba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressStateOrProvince_427c72b0-361b-459f-8a77-deda66fa3aba" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_84b22dea-c2f9-4749-9206-47381c10d79b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressPostalZipCode_84b22dea-c2f9-4749-9206-47381c10d79b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2fe5493a-7c9f-4271-88b5-33c601bb1618" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_CityAreaCode_2fe5493a-7c9f-4271-88b5-33c601bb1618" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a37bd506-5ac1-4f37-a6cc-df5bea56da26" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_LocalPhoneNumber_a37bd506-5ac1-4f37-a6cc-df5bea56da26" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_ea6e3cee-ca0d-46ab-9c76-a7f7b804302d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_WrittenCommunications_ea6e3cee-ca0d-46ab-9c76-a7f7b804302d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7bc642fa-ab30-4613-928f-8fc929203911" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_SolicitingMaterial_7bc642fa-ab30-4613-928f-8fc929203911" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_bc35a338-c0d6-4577-a8d1-fa9a2c35e03c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_PreCommencementTenderOffer_bc35a338-c0d6-4577-a8d1-fa9a2c35e03c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_cfbff824-b7fc-4d45-a0e1-96ed434a991b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_cfbff824-b7fc-4d45-a0e1-96ed434a991b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_730cf496-9b2c-4833-b59c-cbac6067841e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_Security12bTitle_730cf496-9b2c-4833-b59c-cbac6067841e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_17f38e52-1d27-4e6c-a4dc-b0f09f36d332" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_TradingSymbol_17f38e52-1d27-4e6c-a4dc-b0f09f36d332" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_993ca97f-103b-438c-b95c-ba03a760bad9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_SecurityExchangeName_993ca97f-103b-438c-b95c-ba03a760bad9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ebf9cc2f-5bfc-454f-b42a-57b43e623e07" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityEmergingGrowthCompany_ebf9cc2f-5bfc-454f-b42a-57b43e623e07" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4de9e4ae-f6c1-4fa8-a39e-9250dcbedb28" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityCentralIndexKey_4de9e4ae-f6c1-4fa8-a39e-9250dcbedb28" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dc6ae2e1-581d-4b9d-bf92-05f0b5c6b496" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_AmendmentFlag_dc6ae2e1-581d-4b9d-bf92-05f0b5c6b496" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:to="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:to="loc_dei_DocumentDomain_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_7ad92c07-a411-4b2a-9963-87733e4ae709" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:to="loc_dei_DocumentDomain_7ad92c07-a411-4b2a-9963-87733e4ae709" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>unh-20210715_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4b19fdab-f95f-4521-85dc-fc4bc326b269,g:ed81b1ed-4f91-4750-a30e-6fd6374fcf32-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressStateOrProvince_d0431689-32de-442c-b86d-3d8a8d1f31ff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_adfcf77b-5e90-48d5-a692-c9b482dc59db_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_088ef56e-27d0-4106-bc21-548eba939ab8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_d0895d2b-044f-4095-963c-ea299f9a3856_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ae1dd1c3-d6d0-42cd-8f50-53591aa9e786_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fde4ea68-17d7-4885-bbd5-032c1a53cfe3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_db3a44df-07db-4570-b708-71c66a860d31_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_adb00a59-f953-4fd9-90ae-28cc9a686fde_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d1759379-fd53-4308-b75b-311f79f75b40_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_20d2d7a4-b20f-44ce-94da-a3c448007c9c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_edc60587-33f0-480a-bf4b-1650d16ef00b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ebaf5d11-842c-49b1-8b3d-f87767705071_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cb1fe655-bb14-44b0-90aa-c34a00b0a1ba_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ad4f4c9e-7d6c-4d6f-9146-e1d34c95d236_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e0e06d63-3425-48a8-9465-042afcf7aeab_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c59b759f-2f7d-4904-b388-6324b684e53b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b865b585-4b5d-4101-bf12-203c76b11116_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e0e36b16-da22-4c12-a764-9952a433b1b2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_77dce781-f325-4aac-9096-c1be950a7cfa_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0de2a54a-b7a4-4e6d-8bb2-ddf787093f26_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_31254c23-ee93-48b8-9e9b-069b68ac27ff_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d2c825a8-47fd-446e-a0d8-08b5f2638a6d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1dfb0b31-02e3-4711-a2cf-98b2e8c3804f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c2229e1a-6b60-4a47-870f-e93c33b31267_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_4b7c2908-7b94-4954-9c5c-1606f9987ea4_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a2caa45c-95a9-4383-82fa-9b4d5492a404_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>unh-20210715_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4b19fdab-f95f-4521-85dc-fc4bc326b269,g:ed81b1ed-4f91-4750-a30e-6fd6374fcf32-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20210715.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9e6ea4ef-4dfe-48d9-9cc7-1386a0983b5a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e6ea4ef-4dfe-48d9-9cc7-1386a0983b5a" xlink:to="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:to="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_7ad92c07-a411-4b2a-9963-87733e4ae709" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_6dd6ab9d-ae60-44b6-a1a1-56c743f94c9f" xlink:to="loc_dei_DocumentDomain_7ad92c07-a411-4b2a-9963-87733e4ae709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_df1f9e79-bf04-48cd-93c6-f81947c965b8" xlink:to="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e25f4061-14c9-4762-b1c5-0ab400c4ec70" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_DocumentType_e25f4061-14c9-4762-b1c5-0ab400c4ec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_005fb947-b64d-475a-89f9-6148f45b07de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_DocumentPeriodEndDate_005fb947-b64d-475a-89f9-6148f45b07de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_71387310-d232-48a8-a2c7-783b89af99a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityRegistrantName_71387310-d232-48a8-a2c7-783b89af99a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_01e4af33-a396-4310-9dc6-d93c6ee7b710" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityIncorporationStateCountryCode_01e4af33-a396-4310-9dc6-d93c6ee7b710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c7f0e4b6-9b02-4e9c-8761-a622c85f89af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityFileNumber_c7f0e4b6-9b02-4e9c-8761-a622c85f89af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8bf5c78b-2ed8-4d89-9430-60edf68df8ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityTaxIdentificationNumber_8bf5c78b-2ed8-4d89-9430-60edf68df8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f8491496-57d3-429f-bfcc-46de3f1129d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressAddressLine1_f8491496-57d3-429f-bfcc-46de3f1129d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0e410715-0f04-4540-971f-55025a149ac6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressCityOrTown_0e410715-0f04-4540-971f-55025a149ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_427c72b0-361b-459f-8a77-deda66fa3aba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressStateOrProvince_427c72b0-361b-459f-8a77-deda66fa3aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_84b22dea-c2f9-4749-9206-47381c10d79b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityAddressPostalZipCode_84b22dea-c2f9-4749-9206-47381c10d79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2fe5493a-7c9f-4271-88b5-33c601bb1618" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_CityAreaCode_2fe5493a-7c9f-4271-88b5-33c601bb1618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a37bd506-5ac1-4f37-a6cc-df5bea56da26" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_LocalPhoneNumber_a37bd506-5ac1-4f37-a6cc-df5bea56da26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_ea6e3cee-ca0d-46ab-9c76-a7f7b804302d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_WrittenCommunications_ea6e3cee-ca0d-46ab-9c76-a7f7b804302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7bc642fa-ab30-4613-928f-8fc929203911" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_SolicitingMaterial_7bc642fa-ab30-4613-928f-8fc929203911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_bc35a338-c0d6-4577-a8d1-fa9a2c35e03c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_PreCommencementTenderOffer_bc35a338-c0d6-4577-a8d1-fa9a2c35e03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_cfbff824-b7fc-4d45-a0e1-96ed434a991b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_cfbff824-b7fc-4d45-a0e1-96ed434a991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_730cf496-9b2c-4833-b59c-cbac6067841e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_Security12bTitle_730cf496-9b2c-4833-b59c-cbac6067841e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_17f38e52-1d27-4e6c-a4dc-b0f09f36d332" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_TradingSymbol_17f38e52-1d27-4e6c-a4dc-b0f09f36d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_993ca97f-103b-438c-b95c-ba03a760bad9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_SecurityExchangeName_993ca97f-103b-438c-b95c-ba03a760bad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ebf9cc2f-5bfc-454f-b42a-57b43e623e07" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityEmergingGrowthCompany_ebf9cc2f-5bfc-454f-b42a-57b43e623e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4de9e4ae-f6c1-4fa8-a39e-9250dcbedb28" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_EntityCentralIndexKey_4de9e4ae-f6c1-4fa8-a39e-9250dcbedb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dc6ae2e1-581d-4b9d-bf92-05f0b5c6b496" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_54fe0ce9-e4e4-45e7-a1f3-17c986e5b828" xlink:to="loc_dei_AmendmentFlag_dc6ae2e1-581d-4b9d-bf92-05f0b5c6b496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>optumblacka30a.jpg
<TEXT>
begin 644 optumblacka30a.jpg
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M;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
M !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0  @(" @("
M @(" @," @(#! ," @,$!00$! 0$!08%!04%!04&!@<'" <'!@D)"@H)"0P,
M# P,# P,# P,# P,# $# P,%! 4)!@8)#0L)"PT/#@X.#@\/# P,# P/#PP,
M# P,# \,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@!T08G P$1
M  (1 0,1 ?_$ *0  0 " P$! 0$!           )"@8'" 4$ P$" 0$
M                $  ! P," P,%" P("@<' @<  0(#! 4&$0<A$@@Q$PE!
M(C(4=E%AL[05E3<X<4)2TB-U%C87&%@9@6(S)-2UAE>1<D-3TR7%U59(H8*2
M8W,T5?#!T8.39+:B)E1TA)0UIG<1 0                    #_V@ , P$
M A$#$0 _ )_
M
M
M
M                         'G7B[VO'[3<[[>Z^"U6:S4LU==KG4O2.&GI
MJ=BR2RR/7@UK&M555?(!Q!TD=<>*]4F9;K8C26Z/'ZO%*]U;@M.]RI/=,<\R
M!*N5CUU29D_G2-1$1K98F^<K7.4-][Y[^XKT]6W&LHW!MMS9@=ZN*VF\YC;H
M%JXK-4RM1U*^LIX]9NYFY9&K)&URM>C&\J\Z:!LC"L\PO<BP4F4X%E-LR_'J
MU/YO=K54QU,/-HBJQRL5>1[=?.8[1S5X*B*!EH
M
M
M
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MG.8Y/L*![(
M
M
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MCX
M
M
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MG&TR3:_*(KKW#&+><?J-(+K;7OU1&5E(JJYG%%1'IS1NT7D>Y.(&\
M
M
M
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M>*.>"1LT,S4?#,Q4<U[7)JCFJG!45.**@'Z
M
M
M
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M_P#B$&:;89)#?+:O(RY4*Z1UUNJ'-YEIZVF55=%(G'37S7)YS'.;HX#;H
M
M
M
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M<@2(
M
M
M                                  X"\0_J=_5ZV6J;5C=>E/N;N:V>
MSXBL;])J*FY42NN2(FBHL+'HR-=>$KV.XHUR 56557*KG*KG.7557BJJH'\
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M56O:YJHJ.:NBIV ?8
M
M
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MQ+RS4L[419*:JA7SX9F<R<S'HBZ*CDU:K54-D
M
M
M
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MX 9,
M
M
M                           !\M=-4T]%63T=(MPK(())*2@1[8EGD:U5
M9'WC_-;SJB)JO! (A*3PO;QNSN)DF[G5%NLZZY'EURDN-RQ/#6.930L5=(:5
MMRKF=XL44:-B:UM.U4:U-'KV@=^[6=*/3MLK'3RX!M58K7<J1&N9DE;#\H71
M',3B]*ZM6:9FJ\51CFM]Q$T0#P]S^M/IBVB=/39=NY9I;M3HO-8+*]UXK4?Q
MTC?%0-G[IRZ?Y56)[JZ*!'WN/XR.&47K%+M/M)=L@D159#>,GJX;;"BI]NE+
M2>MOD:J]B+)&NG;HO #A?<'Q1^K+-TF@M&1V;;>@F16OIL9MD:2*SR?SFX.K
M9FN\JNC>SWM$X <3YENGN9N)-)49[N#D>9RRNYW+>KI55S45%U3E;/(]K43R
M(B:)Y ,#   ,JP?"\AW%S#&L$Q.A6Y9)EMQI[79J-%Y4=/4/1C5>[L:QNO,Y
MR\&M157@@%R#8O:#'=B-JL-VMQEK7T6+T+8JRX<B,?75LGX2KK)$37SII7.=
MIJNB:-3@B ;:   .7>I#I#V;ZF[.Z#-[&EMRVEA6.Q[@VMK(;K2*B+R,?)RZ
M5$**O\E*CF\5Y.1R\R!7#ZH.B3>#IAN$U;>Z!<KVZFG[NT[BVJ)ZTBHY?P<=
M;%YSJ25=4\UZJURZI&]^B@<<@   #/<-W4W-VZF9/@.X6287(QW-_J2Z5="U
MW'54<V"1C7(OE145%\H$Z?AD;W=4N^F09?5;CY]+DVU>$44=,Z6OH*/UNHNU
M5_(0,K(X8Y7I'$U\DBN<Y47NT['@3*
M
M
M                                                      :%W]NO
M49:\7[SITQ/$,FR-S7^LIE%PJ*9\?D8E+3,CCAE<O%=9:J)$73S7)KH%;[JH
MS+KOK)ZNDZD79K8[#+(L:VYM.M#C3^;S4C8ZW-;0U&G9JKWNX\577B'"P
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MN+/%B.W+I'_S>FJ[8^2.W5D>OHI<I9)4=PU5984=PC0":P
M
M
M
M      8)N%N7A.U=FMU_SN^P6"U76\VZPT-7/KROKKI4-IZ=G#L1%<KWN7@Q
MC7/=HUJ@>%OE>]QL8VHS;*-J**WW;.\9M[[M9K)=*>6IIJ]M&J35%)W<$L$B
MOEA:]L:M>GX3E[4U10B[VO\ &+P&Z+34.[NV%UQ*H<Y(Y;[CM1'=:/CVR/II
MTIIHFI[C'3+Y?> D<VSZE^GC?>G]0P'<S'\JGKV.CEQ>I?ZK<)&*GGM=;:YL
M-0YNG!5[M6^^!I[=[P[^EK=WUJLFP)F 9!4HY?R@PYS;4_G=Q5[Z1K'T;U5>
M*JZ#F7[H"*C>3PC=YL2]:N>T636S=2T1\SX[/4\MGO")VHUK)GNI9>5."N[]
MBKY&<=$",'-< SC;B]2X[GV)7;#KY$BJZV7BDEI)7-1=.=B2M;SM7R.;JB^1
M0,1   -H[+;49%O?NCAFUN+L5+IEMP92OK%8KV4E*W62JJY$3CR00M?([W4;
MHG%4 N2X#@^.[:85B^ 8G1-M^.XC;8+9::9$37NX&(WG>J(G,^1=7O=VN<JN
M7BH&7        <G=3G1QM'U0V9R95;TL&<T=.L./[C6V-J7"FTU5D=0GFI50
M(Y=>ZD7AJ[NW1N<K@*T74?TH[M],61K:\\LZU>.UTKF8WG=O:^2UW!J:JC6R
M*FL4W*FKH9-')VIS-T<H<T@20^&)L)^EWJ#I,SO%$Z?#]FV0Y!6R.;K%+=U>
MJ6JG55\J2,?4?_)T7M F \27?O\ 0MT[7FS6FM;3YINTLV+V!C7*V:*CEC_U
MI5LTX_@X'=VCD5%:^6-WD JQT]1/23PU5+-)35--(V6GJ(G*R2.1BHYKV.:J
M*BHJ:HJ 6Z>BCJ&@ZD-A\:RVLJFRYK842P[A4_!KDNE)&S6HY4TT;51N;,FB
M:(KG,3BQ0-6UW4W4=-G4#/LEOO7NCVOW!D^5]D]V*UZ-BH(9UY9[-=9G<.[I
M9U5D<[G*YD;HEF7E=SL"06.2.6-DL3VR12-1\<C%16N:J:HJ*G!45 /]@
M
M
M
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MM]7#7T%?#'44-=3R-EAFAE:CXY(Y&*K7-<U45%1=%3B@'T@
M
M
M
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M144#TP
M
M
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MUMGO%%(DL%1!*G,R2-[>"HJ >T
M
M
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M9;K-:*.*WVJT4L-%;*"!O+%!3T[$CBB8U.QK&-1$3W /O
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M45%1=%14 ]X
M
M
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M1=>+5T5/X%310/\ 0
M
M
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MIHJRTW:CE;-3U-/,U'QRQ2,56N:YJHJ*B@>F
M
M
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M&FS53NW?Z'N<NWB[NIMO>MTDIL?IU7U)J:]GK3E=4*J+HYBPZ\6@2G@
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MV:"H@F:CXY8I&*K7M>U45%1=%0#[@
M
M
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M+%0VZW01TM!10-1D4,,+49'&QJ<&M:U$1$3L0#ZP
M    !JK%-G,)PS<O<S=:PT"TN4;L16AF5O\ -[MS[1'-%')$U$3D65LJ=[IZ
M3FHY>($"/BZ[HKE._.,[:4=5WMMVML+'5U.CD5&72]*VJFU1/_M64O;[_P#"
M$3P "5?P]^O&?9.XV_9O=:O=4;17FLY;'?IWJKL;JJAW%RJY?_)2/761O^35
M5D;P5Z."R13U$%7!#54LT=335,;9:>HB<CXY(WHCFO8YJJBHJ+JBH!^H
M
M
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M:!&#N]X1V^.(+67':K(K1NO:(M706Q[DLUX5NNO*D-2]U*_E3RI4-5WD9QT
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M3BBHH']
M
M
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M+'A>.V7$L9H4M>.X[214%DMC9))6TU+ WDBA8Z5SW\C&HC6HJ\$1$3@B >\
M                          #_ "KVM5B.<C5>O*Q%735=%71/=X(J@?Z
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M:_R>H3.
M
M
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MTCB:C&\TDCG/>NB<7.557M554#Z@
M
M
M                         #B3K]Z@TZ?NGS(JVTUJ4V=9XC\:PA&.TEBF
MJHW>M5K=.*>JP<SVNTT218T7T@*FP     =7[%=%/4-U!NI*W#,)EM6*52MU
MSO(%=;K2C'?Y2*1['2U*>[ZO')IY= )F=C?";V5P1*.\;N7:KW=R*+21]K5'
MVVQQOTUY?5XGK//RKY9)4:[3C$G8!(->LGV8Z?,0ITO-UQ7:/#+>QS;=0JZE
MM-)YC=5CI:9B1\[]$X,C:KE\B 1J[R^+SM7C2U5KV7Q"X;DW)G,R+([ISVBT
MHNJHU[(WL=5S)PUY71P_XP$>E+U1=7G6INKB>T%-N)4XE;\\N;**2P8HQUKH
MJ6B1'2UD\SX7>M3QP4['R.;+,]%1NB(!8JRS(L&Z:MD+E?IXDM^#[2XVQE%0
MHY$DDCHXFP4E*QZIHLM1)R1M5?2>Y->T#6O1EU"_K*[%8_GU?W$66T-3467.
M**G3ECBN5(J.YFMT31)H)(ID1."<_+]J!%_OKU0]1O0MU(9/AL%U_2%LYD<O
MY385BF3.?4)!;;C(YTE+17#_ ,S E+.V2"-CGR,:QK5[OS@.[M@/$>Z>-[FT
M%INEY_15G-4K8EQC)961T\LSOM:.YHC:>5%71K4D[J1R]D8'?B*CD1S51S7)
MJBIQ144#^@                      *AW7+N8NZO5-N[D,-2M1:K5>'8[8
MM%UC2ELK4H4='_%EDB?+]EZ@27^$9U%^M461=-V3W)%FMZ39#MFD[^+H'NYK
MG01:Z>@]4J6-3551TSNQH'6'6/E&X'3)D-AZK-N:5U]Q9RTN-;\[?O>Z.EN-
M"YZMMET1R(Y(:BGD>M/WW*JJCXF.18VJ@'3V#9UL[U9;/ONEI2CS7;[-*-]#
MD./5[&K+!(Y$[ZBKH$<JPS1+HO!>"\LD;E16/4*[G7!T*9#TRWEV7X<E9DVR
M]ZGY*"[R)WE59IWKYM'<%8B(K5_R4VB([T7:/TY@CR R;$LTR_ ;U3Y'@^47
M7$;]2<*>\6>KFHZAJ+VM[R%S7*U?*U>"^5 )2]C/%MW:PWU.S;TX_2[IV&)&
MQNR"C1EMOD;$1$YG*QOJU3HB<$6.-SEU5TJ@3;[ ]2VTO4MCU=D&UMZJ:Y;*
MM/'D=EKZ66DK;=+4M>Z**=KD6-RN2-VCHI'LX+YP&_
M
M
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M\?))D&:?)['KP5\5LM].]JIYJ<.>L>GI+Q1>">4)>P
M
M
M                                     .0^N'?Y>G?I\RO*K95)3YGD
M*)CF!:+H]ERKF/3UEO\ _*PMDF3AIS-:U?2 J,O>Y[G/>Y7O>JN>]RZJJKQ5
M550/\@=&;!=*F]?4C=4H]M\5DDLL$O=77-KDKJ6S42^5)*I6NYWIJGX.%KY.
M.O+IQ GUZ;_#,V1V6]0R'.88]X<^I])$K[Q3M2T4DO:GJMM<LC'*U>R2=7KJ
MG,U(UX ;\W_ZQ-A^FRCFI<VRF*KRN*!'V_;RRHVKNTFK=8T?"U493,<G8^=S
M&JGHZKP @LW^\4#?S=I:^RX'4-V;PRI1T3::RRK)>9HE_P ]=%:Q\:K_ /;M
MBT[%5P$;5143U<\U55325-34R.EJ*B5RODDD>JN<][G*JJJJNJJH'Y  ,SV[
MP/(-T,ZQ/;S%:;UO(<QN=/:[7&NO(U\[T:LDBHB\L<;=7O=]JU%7R 7$+3;L
M#Z:-CJ>A;*ELP+9_&'/J*E_*DCZ>WP+)-*Y.".FG<CG*B>E([AQ4"H)N_N;?
M=Y=SLVW0R142[9G=):^6G1>9M/"NC*>F8JZ*K((6LB;KQT:@&&6*]W3&KW9L
MCL=8^WWK'ZZGN5GKX].>"JI)6S0RMUU35CVHJ 7(=H-P,7ZD]B,6S2:@IJZP
M[EX\Z#)K"Y5D@;+-&^DNE _7BYK)4EB77M1-?*!4KZ@-I+EL7O)N!M9<N\D_
M)2ZR0VNKD31U3;ID2>AJ%X(FLM/(QRZ<$553R :=  =W=.'B$[\]/JV^QRW5
M=R-NJ1K(4PK()7R.IH&Z(C;?7>=-3<K4T:U>>)$_R6O% GWZ=.M[8GJ1AIZ#
M&;_^3.=/;_.=O;\YE-<%<B<5I'<RQ5;>U4[IRN1.+V,UT Z_
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M'?@
M
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ML B>KJZMN=957&Y5D]PN%=*^HKJ^ID=+--+(JN?))(]5<YSE5555755 ^4
M  36>$-L%\K9'EG4/?Z%'4.,))C>!/E3MN%1&CKA5,UTT[JG>V%%[%[V1.UH
M&W_%VW[_ "?PK%NG^QUBLN></9?\T;&_16VFBE5*.![4772HJF+)_P#(]\"O
MH  G(\'[?-8JK.NGR]UB)'5-=EF#,D=I^$9R07.F9S+Q5S>ZF:UOW,KO= ]S
MQ@=C4J;;@G4%9:1.^MKDQ3.'1M35T$JOGMM0_33T).]B<Y=57GB;V(! V
M?K3U$])/#54LTE-4TTC9:>HB<K)(Y&*CFO8YJHJ*BIJBH!*9TT>*5NKM6E!B
M^\<-3NY@\/)$R[2R(F144341/,JI%1M8B)QY:A>=5_RS4X 3W[,;_P"TN_\
MCR9'M;F%)D,$2)\I6M56"XT+U^TJZ.3EECX\$<J<KNUCG)Q W(
M      A-\6/I\WBSRKQ?>'%*-<IP# K!)0WVP4+'/K[8]U1)/47)T2:K+ YB
MQM>K.,:1\SF\G,] @-  9+AF77_ ,MQO-\6KG6W(\4N5-=;+6MX\E12R)(SF
M;V.:JMT<U>#DU1>"@7#-J,_PSJ>V)L66I1P7#&=RK#+1Y/C[W<[(I)HW4MRM
M\OE_!R=Y'KY4T<G!4 JA]2FR-VZ>=Y\TVMN;I*FFLM5WV.761O+Z]:JE.]HJ
MCAPYEC5&O1-4;(U[?M0/*V.WQW Z?-P+7N)MW=%HKG1+W5RMLO,ZCN5&YR++
M1UD2*G/&_1/*CFN1'L5KVHJ!:JZ<^I/:[JQV[DO&/+3NKO54I,_V\N')/46^
M2H:YDD$\;F\LT$R(Y&2<O+(W@J-<CF-"%[KX\/:HV=6Y[Q;+T%1<=K99'U&4
MXJQ%EGQU7NU[V)>+I*+5=-5U=#]LKF><T)O^E?&UQ+ILV)L+XUAGI,&L<E;$
M[75M34T4514)Q]R61P&_
M
M
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ME>J++1UD2*B20R(B:IJBHJ(YJM>UKD"UATQ=3NW75?MTZ^V)L5)?*2)M)G^
M5;FS3V^>9JHYKFJB)-3S(CN[DY='IJUR->U[&ATU2TM+0TM-145-%1T='$R"
MDI(&-CBBBC:C6,8QJ(C6M1$1$1-$0#]P
M
M
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MBN[])M]LO;]HK)6I%E&[TZQW1C/3AL%$YKZI55%U:M1,L<2:IYS.]3R 5L@
M  !9(\)O?),[V5NVT=XK.]R+:*K1+6R14YY+'<GOEI^77B[N)TEC7MY6K$GE
M0#AKQ:-CTP?>:R;OV>D[JP[M4:LO#F(G)'?+8QD4RJC41&]_3K$]->+GME<!
M$X     $IGA.[-KG>_MPW+N-(LMAV@MCJJFE<FK'7BYM?34;%35$7EA2HEUX
MZ.:SW44"53K\ZO;UTKXSMV["J>VW/-<MOCI'VFYL=+ ZS4$>M9SI&]CV*^26
M%C'(J?;*FO*J 9-TO=>6S74M%1V.FJ_R%W-='_.< N\K>>=[4U<ZVU.C65;=
M$5>5$;*B(JNC1OG*';P           X\Z]]R5VPZ4=W+O3U'J]TR&V)B]GT5
M6O=->WI12K&Y--'1T\DLB+Y.7AQ J<8YDE_Q"^VO)\6O%9C^0V2H;56B\T$K
MH*BGF9Z+XY&*BHOD]]."\ +%'1-XD5@W?2T[8;WU='BVZ4BLI;'D[N6GMF02
M+P8Q>QE-5O[$8OF2._DU:YS8@-T=8_0=@?4Y;JG)[)ZMA>\=' C;?EK(^6GN
M21M1K*:ZLC15D:C41K)43O(TT]-C>[ K*;F[7YWL[F-TP+<;':G&<FM+OP]%
M4(BLEB<JHR>GE:JLFB?HO*]BJU?=X*!B5FO%TQV\6K(+)6RVR]6.L@N%HN4"
M\LM/54TC9896+Y',>U')[Z 7".FO>BP=3FQ&,YZZEI)I+]126K.L>5$DAI[E
M"WN:^E?&[F_!OUYV-=VQ/8J]H%87K"Z?ZOIOWURO 6QR+C%6Y+U@5:_5>^L]
M:]ZP-5R\7.@<U\#U\KHU7L5 .7P.L>AR[9A;>JO9.##;[66.HN^3T-%?O5'J
MC:NT+,V6X4D[-4:^.6"-R*CM=%T>GG-:H%O,
M
M
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ML9/E^/4*U.?;0I47NTQ11\\U9;'-:MSHVHWBJ]W&V9B(BJKH^1J>>J@5=0)
M_##QM;_UB8!6.B66#%;=>[Q.B(JHFENFI(W.T1=-):EBIV<=/L*%J$
M
M
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M6.V,1B]NJ<SO_B&-_OFL\]=Y_P!!]A^3]?\ RORO5=]IIV=]W'+V\?Y/WO?
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MU\@>K_+?R+6Q5GJOK7>=QWW=.7E[SN7\NO;RK[@&R0  #\IIHJ:&6HGD;#!
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MXF$;IXO;\TV\R>@RW&+HB^J7:WR<[.9-.:.1JZ/BD9KHZ-[6O:O!S44#,P
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M('%W@T8P^BP;?'+)(58Z\9!:K+S.145'6JFFG<WBO#3U]-4T3WU7R!-&
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MA^"D M[   %=;QCOIRVO]A6_UG6 1"   $R_@T_29O-[,4'QU0+!H
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M,7@K51=',>QR*U['(CF.16N1'(J 96      "$KQGOS9V"_&>0? T $"
M             !VIT9]9&7]+&9-BD=/?MJLCJ8_RUP]7JO(JZ,^4*'7@RHC:
MB:IZ,K4Y']C'L"U;B.6XYGF,6+,L1NT%]QG):.*OLMVIEUCF@E35J\=%:J=C
MFN1'-<BM<B*BH!D8 #A;Q*_J4;T_V<__ "2U@51
M=7=#/UN-AO:>'X*0"WL   5UO&.^G+:_V%;_ %G6 1"   $R_@T_29O-[,4'
MQU0+!H            5F_%O^M1;O86T?&JX"+\   G2\%G_F4_L;_MP"=(
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M\[<YJM23=2ZNC54T1R?(ED35/=XHJ 2^
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MH!9/MJU[K=0.NC8FW-U-$MQ; BMB2=6)WJ,17/5&\VNGG+P\J]H'V@
M    #QLAR&R8G8KQD^2W2GLN/V"CFK[S=JIZ,AIZ:!BODD>Y>Q&M15 JL];G
M63D'5+FWJ5J=46;:+%*F5N%XZY58^J=Q8MRKF(JHL\C?0;V1,7D;Q5[GAPT
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M'31.*@0$?NONLC^[ZV?/]K_I #]U]UD?W?6SY_M?]( ?NONLC^[ZV?/]K_I
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M 6(0  "NMXQWTY;7^PK?ZSK (A   "9?P:?I,WF]F*#XZH%@T
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MU.]G=O9+>7]_3LD:O%'QTG<L<B\=6KV=B!W$
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MJ7'+]3]->X%U<['<DG>_:VXU+]4HKG(O,^V<SO1CJEU=$FO";S415EX!8$
M   "$KQGOS9V"_&>0? T $"   !)'X4_UN+/[,7OX)@%H$      'XU--3UE
M/-25=/'54M2QT=133,1\<C')HYKFN145%3M10(Y>H[PS]C=Y:6OO6!6^GV?W
M >UTD%QLT",M%5*B+HRKMK%;$U'+VR0(Q^J\SN\]$"NEO-LGN+L'F]=@.Y=B
M=9[U2IWU'4L7O*.OI7.5L=71SZ(DL3^5=%T1475KVM>CFH&J   #T+1=KC8;
MK;+Y9ZN2WW>S5<-=:Z^+1)(*FFD;+%*Q5UXL>U%0"Y;T\;M4>^>RNW6Z=(D;
M)<KM,<MWIHM49!<H%=3U\+4557ECJ8I&MU[41% W.          4[>L3ZU'4
M#[=7KXT\#FT   LR>$A]5>X>W5W^*T($H            KK>,=].6U_L*W^L
MZP"(0   F7\&GZ3-YO9B@^.J!8-            "LWXM_P!:BW>PMH^-5P$7
MX  !.EX+/_,I_8W_ &X!.D   >%E'YLY%^+*OX%X%'@       "Q]X7'55^D
M[ G[%YI<4DSK;2B8N+54[U66Y8^Q4C8S5VNKZ%5;&O'C&L>B+RO4"68
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MDJ>35L-.UD7-SJQ\@6!D1&HC6HC6M31K4X(B(!_0
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M572/>NKGO>JO>Y5<YRN55 R\
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M@<V@  %F3PD/JKW#VZN_Q6A E            %=;QCOIRVO]A6_UG6 1"
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M<R]U5AQ.WNKJJW6JXWRZS+JD5+;K53/JJNHF?HJ-:UC-$U])ZM8GG.1 ,'
M  %VK:[Z,]NO9BT?$H@,Z
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MJ\S6AQ4  G-\&''%6??S+I6:)''8+112:+QYUKJBH3733ARQ?^V@$ZX
M    !HWJ5W6CV2V(W/W-29D-?C5DG6PK(B*UUTJM*6WM5J]J+4RQZ^]J!32F
MFFJ9I:BHE?/43O=)//(Y7/>]RZN<YRZJJJJZJJ@?D   3I^$5T[Q.9D?4GDE
M$CI6/J,;VW;-'Z'FM2Y5\3E\J\WJS7)_WS5[0)T0              *X/BM]
M.46W6Z%MWLQBWI38KNS))'DK(6Z14^1PM5\KUT1$3UV).]]UTC)G+V@1,@
M'W6RY5UFN5ON]KJ7T5SM53%66ZLCX/AG@>DD<C==>+7-14 NB;([D4N[^T6W
M.YE*C6)F=AH[C5T[.+8:M\:)50)_X4Z/9_ !M(   A*\9[\V=@OQGD'P- !
M@   21^%/];BS^S%[^"8!:!          ((O&CHJ>.NZ<[BUFE75097332>[
M'3NM#XT_@69_^$"#@   D/\ "VJYJ?K#PN&-41E?9K]!4:IJO(EOEF33W/.C
M0"TJ          4[>L3ZU'4#[=7KXT\#FT   LR>$A]5>X>W5W^*T($H
M        KK>,=].6U_L*W^LZP"(0   F7\&GZ3-YO9B@^.J!8-
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MEM:<W%KDU[R=$1/PB\BZ]TU0*X@    NU;7?1GMU[,6CXE$!G0
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MG-4NJ5_]E E4   (2O&>_-G8+\9Y!\#0 0(   $D?A3_ %N+/[,7OX)@%H$
M         @ \9K)Z>KSK8[#6R-6JL-AN]ZFB33F2.[U4%/&Y?+HJVUVGV% A
M:   )*_"@M3KAU9T56V-CTL6)WJN>YR*JL1Z0TG,S1%T76H1..G!5^PH6>0
M        "G;UB?6HZ@?;J]?&G@<V@  %F3PD/JKW#VZN_P 5H0)0
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MN\_L+D7]65 %+(    7:MKOHSVZ]F+1\2B SH
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M-9D6*T=Z6/CYSK/6I3HJ+IIP2Y+Y?_>!83   (2O&>_-G8+\9Y!\#0 0(
M$D?A3_6XL_LQ>_@F 6@0        'Y5%1!203555-'34U-&Z6HJ)7(R..-B*
MYSWN<J(B(B:JJ@5 .LC>N+?WJ(W S^W3K-C253+/AR\41;7;6]Q!*U%U5._5
MKIU1>Q9% Y?   )J_!IPF6HS/>?<>2)6PV>RV_&Z.=6\'NN50ZLG:UW\1*&)
M53^,@$_(         !3MZQ/K4=0/MU>OC3P.;0  "S)X2'U5[A[=7?XK0@2@
M           "NMXQWTY;7^PK?ZSK (A   "9?P:?I,WF]F*#XZH%@T
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MG]A<B_JRH I9    "[5M=]&>W7LQ:/B40&=
M                                 (W>J?PV]I]^%N678*D&UNZ-2KYY
MKG1Q?ZIN<SM7*M?1LTY7O=VS0Z.U57/;*NB 5Y-Z^G[=CI\R9^,;HXI46.>1
MS_DJ\,_#6VXQL73O:.K9YDB*FBJW@]NJ<[6KP TP   3Q>#1M^Z.U;T;J5,.
MK:RKM^*6>HT[%IHW5U>W7RZ]_2KHGN?8T#6_C(;@.N&XVTVV,$VL&,6&JR&O
MC8O!9[O4>KQ->GW3(Z%53WI/? AE   )>?"7Z@FX5N5>]BL@K$AQ_=#6OQ9T
MBZ,AOU)%YT:*NB)ZW3,Y=5[7Q1M3BX#LKQ7^G]F?;0V_>BQT?/E.TCN2]+$Q
M5DJ;!62M;*B\J*J^JS.;*FO!K'3. K>    "3SI%\2?/]CODK!=TDK-Q]JH%
M93TLKGH^]6:%.">J32*B5$3$[(97)HFB1O8U.50LL6FY4MZM=MO%$KUHKM2P
MUE(LC%C?W4[$D9S,=Q:NCDU1>P#T          "I[XD%UENW69O(^35L=!+9
MJ&GC547E93V:A:NBHB>D_F=Q]W0#AT   EU\'6PQ5>^VY&12-1[K)@[Z.!%5
M/-?7W&D=SHFFNO+3.377L5>W7@%B\                 K!>*WCK++U;7.Y
M,A[IV7XM9;M*_E5O>.B9);>;71.;A1(W7WM/(!&P   2/^%5=GV[JZL-&Q7(
MV_8W?*"31&JBM93I5^<J\436F3LXZ^]J!:%   (2O&>_-G8+\9Y!\#0 0(
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M=>S%H^)1 9T
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MWM731% N!4E)2V^DI:"AIXZ.BHH604=)"U&1Q11M1K&,:W1$:UJ(B(@'T
M       %.WK$^M1U ^W5Z^-/ YM   +,GA(?57N'MU=_BM"!*
M *ZWC'?3EM?["M_K.L B$   )E_!I^DS>;V8H/CJ@6#0            K-^+
M?]:BW>PMH^-5P$7X  !.EX+/_,I_8W_;@$Z0  !X64?FSD7XLJ_@7@4>
M!=JVN^C/;KV8M'Q*(#.@/XJ(Y%:Y$<UR:*B\45% J[>(STGKT_;HKFF(6WN-
MJ-S*F:JLT<+%2&U7-=9*JV\/-:Q>,L"</,YF(GX)5 CE        EG\+WI.7
M<[./T[9Q;%DP+;JM:F)T=0Q%CNE^BT>Q^CO2BHM4D7R+*K$U7E>T"QZ  U1O
MS]!N\_L+D7]65 %+(    7:MKOHSVZ]F+1\2B SH
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MXWB.Y]4]KHF*WFQ[ [1;Y=$5%YGU=?6<=>U=*E.SR 1>   $BWA8VZ6MZO\
M%:F-51EHL-]JY]&JY.5U&ZF354]'SITXK]CR@6C@  "$KQGOS9V"_&>0? T
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M -4;\_0;O/["Y%_5E0!2R    %VK:[Z,]NO9BT?$H@,Z
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M2EHG+Z<KM5;+.G:GF,T9S+($D             4[>L3ZU'4#[=7KXT\#FT
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MYK&*!W^   :HWY^@W>?V%R+^K*@"ED    +M6UWT9[=>S%H^)1 9T
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MP           @U\9C!%=2;*;FT\"\L,MSQB[U.G!5E;'6T+-?)_)U*@02@
M'O8KD=SP[)\<RZRRI!><6NE'=[3,O8RJH9V5$+N'N/8B@75=O,VL^Y6"8?N!
M8'\]FS.ST=YMR*NKF1UD+94C?P31S.;E<BHBHJ*BH!F(              &L
MMY]Q[?M#M1N#N9<U;ZOAECJ[E%"_LFJ8XU2F@356\9IE9&G%.+DX@4M;E<:V
M[W&ONURJ'5EQNE3+5U]6_3FEGG>LDCW::)JYSE50/B   +&'@]X"^Q[);@;@
M5%.L-1GV3MHZ254T[ZALE.C(WHNG%$J*JH;]E% ET   (2O&>_-G8+\9Y!\#
M0 0(              _6GIYZN>&EI89*FIJ9&Q4]/$U7R22/5&M8QK455557
M1$0"1GIZ\,O?O>*:AO&;4+MG<%G1LKKK?(56ZU$:\=*6U\S)454T\Z=8FZ<6
M\_8!/[T^]+6SO338G6K;?'4;=JR-K+YF5Q5M1=[@K=/Y:HY6HUFJ:I'$UD:+
MQ1NNJ@=$@             IV]8GUJ.H'VZO7QIX'-H  !9D\)#ZJ]P]NKO\
M%:$"4            5_O&9H)(\]V/NB\O=5E@NU*Q$1>;FIJJ![M5TTTTG33
M^$"%P   E+\(K(&6GJ>OEHFEY691@MSHZ>)55$=/3UE#6-71$754CAD[53M7
M["A99            "KCXIU[2Z]7^5T"2*]<9L-BMKFJNO(LE&VNT1-$T_\
M-ZZ>^!'2   3Z>#%:NYQ/?J]]VU/E"[6&A[U%7F=ZG!62\JIV:)ZUPT]U?>
MFP   /"RC\V<B_%E7\"\"CP    +M6UWT9[=>S%H^)1 9T   ?Q41R*UR(YK
MDT5%XHJ*!5V\1GI/7I^W17-,0MO<;4;F5,U59HX6*D-JN:ZR55MX>:UB\98$
MX>9S,1/P2J!'*   2X>%QTG)N1FGZ?,YMB2X-MY6HS#:&I8O)<K]%H]LZ(OI
M14.J/U[%F5B(J\CV@6-    !JC?GZ#=Y_87(OZLJ *60    NU;7?1GMU[,6
MCXE$!G0
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M#7HYOVH&D0+!'@T8YZKMSO5EW=JBWO)+;:.]\CODJC?4<O9Y/E#W?+_A"9P
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M6JBL]"UKIG0P(BR/1'*U-&HO'B!O?]1GJX_N&R?_ .C%_I 'ZC/5Q_<-D_\
M]&+_ $@#]1GJX_N&R?\ ^C%_I 'ZC/5Q_<-D_P#]&+_2 ?Z9T+]7+W-8FP^3
M(KU1$5T<+4X^ZJRHB?94#,K5X;_69=I>[9LW+01M5$DJ*Z\V:G8W5%5%T=7<
M[NS3S6K[X&\<4\(CJ4O+HY,DR'"\.I5T[YDU=4UM4FNOHQTM*Z)VFG'69.W[
M.@=A;>^#GM?:705.YFZ609E+&J/?;K+3066E<OW#W2K72N;[[71K]@"1G:7I
MEV'V.8QVV.V5GQVX-;R.R!T;JRZ.14T<BU]6Z:HT7RM1Z-]X#>P
M      "G;UB?6HZ@?;J]?&G@<V@  %F3PD/JKW#VZN_Q6A E
M$+GC,XV^JP'9#+TC58[%D%VL[I=%T:ZZTL-0C57FTX_)R^1>SM3RA7^   .J
M>B//H]MNJO93):FH]6H9\@99+E*YW+&V"]Q26Q[Y->'*SUE'KKV<NOD M]@
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MY[$91U&[L8WMCC*.IVW&3UG(KYW?>1VRUPJBU59(FJ(O*BHUC55.>1S&:IS
M6_MN\ Q?:S",8V\PNWI:\8Q*@CM]II-=7<C.+I)':)SR2O5SY'+Q<]SG+Q4#
M,P   !JC?GZ#=Y_87(OZLJ *60    NU;7?1GMU[,6CXE$!G0
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M;\[:8UN;A-6V>U7^G1:JA5Z.GH*UB(E315*)IRR0O\U>'G)H]NK7-50VL
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M65 %+(    7:MKOHSVZ]F+1\2B SH
M                                      '\5$<BM<B.:Y-%1>**B@1<
M=4WAA[8[P?*.7[1.I-J=Q9^>:>@BC5N/W.9>*K/31-5:5[ET_"0-Y>U71/<O
M,!7ZW?V0W1V(R>7$]T<2K,9N.KUH*J1O/1UT3%T[ZCJF:Q3,]]JZIV.1KM4
MP;%LFOF%Y)8<NQFX26K(<9KZ>YV6Y1>G#4TLB2Q/37@NCFIJB\%[%X 7"]GM
MQ,/ZI-@K!ETM#3UM@W'L,UOR_'7+SQPSR,?27.@>BKS<K9.\8BKHKF<KOMD
MJC]1VREYZ?=X\TVON[99(+)6.EQVY2IIZ]:JA5DHJE%3@JOB5$?IP:]'-^U
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MZ#=Y_87(OZLJ *60    NU;7?1GMU[,6CXE$!G0
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MW*JEM-)*_:_-7S7+;RY.57I%&CD6HMTCUX]Y2.>C4U55=&K'*NJN1 XG
M'672UUA;H=+&0NJ,9G3(,'NDZ2Y1MY72N;15:JB-6>!R(Y:>H1K41)6HNNB(
M]KVHB 66NG?JTV9ZE[,RKP'(6TV24\227K [FK:>[T2_;*L/,J31II_*0J]G
M9JK7>:@=,        <T=0_5GLUTT65]9GV0MJ<CGB5]EP.V*RHN]:J^BJ0<R
M)#&OEEE5K/(BN=HU0K1=4O6!NCU3Y$RIRBH2P81:IW28OMY02O6AI.UK9IW+
MHM34<JJBRO1--7)&UC7*T#D\    2C>&=TF3;R;BP[OYI:U?MCMG6QS4$4[=
M8;O?8>66"G1JIH^*FU;++Y%7NV*CFN?H%EX     (2O&>_-G8+\9Y!\#0 0(
M   $D?A3_6XL_LQ>_@F 6@0                          IV]8GUJ.H'V
MZO7QIX'-H  !9D\)#ZJ]P]NKO\5H0)0             K6^*[L7)@&^%%NQ:
M:)8\9W>I4FKY6-TCAOE QD-4Q=%5$[Z+NIDUTYG+)]RH$5H    G@Z#O$@MG
MR;8MENHB]MM]5;XXZ'#-TJZ32":&-$9#27:5WH/:B<K:AR\KDT[U4<G.\)P(
MI8IXHYX)&S0S-1\,S%1S7M<FJ.:J<%14XHJ ?H     '^))(XHWRRO;'%&U7
MR2/5$:UJ)JJJJ\$1$ A"Z\O$?M<=LO6R_3O?$N%?7MEH<VW.HU1:>"%R*R6C
MM4J+^$D>FK7U#?-8W^25SUYXP@;    $XG@_[%2RU^;]0M\HE;34D;L5P1\C
M>#YI.66YU+->*<C4BA:Y."\\K?(H$\     \+*/S9R+\65?P+P*/     NU;
M7?1GMU[,6CXE$!G0              &J-^?H-WG]A<B_JRH I9    "[5M=]
M&>W7LQ:/B40&=
M                           #FS>SI5VJWMN%KRNZ6^7%=S\;G@K<4W3L
M*MI;Q155(YKZ9SW\JLJ61N8W1DS7(B:HQ6*NH'0LE%'6VU]NO$5/=(:NF6FN
MD,D*+3U+9&<DK70O5Z<CT545JJO!=%U ^X              #2'4+L-AO4=M
MA?-M<RA[N*M3UFP7R-J.J+7<HFN2GK(==.+5<J.;JG.Q7,7@X"I!O5LSG6PF
MX5\VXW MCJ"\6F15I*QB.6EN%&YSDAK:.1R)WD,J-U1=-475CD:]KFH&J0
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MS9V"_&>0? T $"   !)'X4_UN+/[,7OX)@%H$
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M5&_/T&[S^PN1?U94 4L@   !=JVN^C/;KV8M'Q*(#.@
M
M               '*?5ATFX)U4X,MDOJ,LF:65DDF$9U%$CYZ"9W%8I416K+
M3RJB=Y&J_P 9JHY$4"J]O/LIN'L'G5RV_P!R+)):;Q1*KZ*K:CG4=PI5<K8Z
MRBF5$26*3E71>U%U:Y&O:YJ!J@                 Z7Z9.EC<GJAS-F/8=
M1K;\<MTD;LOSBJC<M#;*=SDYN/!)9W-76.%J\SNU5:Q'/:%JW8[8[;_I\V_M
M>W>W=K2BME$G>W*Y2\KJRY5CFHDM962HB<\C]$\B-:U$8Q&L:B(&X
M0E>,]^;.P7XSR#X&@ @0   )(_"G^MQ9_9B]_!, M @
M        !3MZQ/K4=0/MU>OC3P.;0  "S)X2'U5[A[=7?XK0@2@
M     AQ\2_HEJ=P:2LZ@]I[,ZJS:T4S?TB8U1Q\TUVHJ=J-9701M35]13QHC
M7M3B^)J<OG,1'A7I                ?31459<:RDM]OI)J^OKYHZ>AH:>-
MTLTTTKD9'''&Q%<YSG*B(B)JJ\$ M ^'ST9LZ;\+ES7.*6*7>/.J1B7>/@]+
M+;U5)&6V-_'61RHU]0Y.'.B,35L:/>$C0     >%E'YLY%^+*OX%X%'@
M7:MKOHSVZ]F+1\2B SH              #5&_/T&[S^PN1?U94 4L@   !=J
MVN^C/;KV8M'Q*(#.@
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M0;O/["Y%_5E0!2R    %VK:[Z,]NO9BT?$H@,Z
M
M             'Y30PU,,M/41,GIYV.CG@D:CF/8Y-'-<U=45%1=%10(O.HS
MPL]G=U'UV2;4U+=GLRG1TCZ"EA[['ZN555WX2B16NIE<NB<T#D8U./<N4"$S
M>WHMZBM@Y*NHS3 *JXXU2\SORWQ]'7.T+&W_ "DDT34?3HOD2HCB=[P'*P
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M*(#.@
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M*C4UT1$U\B >L
M
M
M
M
M
M
M
,            ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>uhclogoa02a01a01a01a37a.jpg
<TEXT>
begin 644 uhclogoa02a01a01a01a37a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +P#< P$1  (1 0,1 ?_$ '\   (#  (# 0
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MU-5[%E[O]3O^-"6C&S2[P,'C*()+W&YD7D[''P4HPBDE *9DV<*/S\C"FF<
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# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>uhglogo1a02a01a01a01a42a.jpg
<TEXT>
begin 644 uhglogo1a02a01a01a01a42a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
M D; ^0.!\AU]+_\ E?Y#,Y7^7)\&Z[/3551DI?BOT>C3UD?CJ9Z.GZ^P5-BI
MI"4C:?R8J&$K,UVG4B1F<L6.%'/*1Q\Y;HL0 3Z^?APKXC$_SKCRX=9D\E/(
M_*&V-+4O]##Q]/#4#^5,^?'KYN'\TGY#9/Y0_P P'Y4=MUF0FR&)JNV]S[/V
M0TK.(Z?KOKFM?86Q(Z>E)\=#]UMK;U/53Q)Z35U$SDL[N[9G<B[.FQ<I6&WJ
M )!;J[_\U)!XCY\Z,Q /H . IUA[SMNS[WS7?7[$F,W#(G_-.,Z$QY5502/4
MD\37KZ!O\CCXY83XX?RSOC10T6.I:;<?<&S*#Y ;VR<20BKS>7[>I:?=> FR
M$D2J7GP^PJK$8Q5;U1QT2JWJU>\2/=#>9=YYVO79B8;>4VZ#R40G0U/MD#M_
MMNLK/;39X]GY,LU4 37$8G<^9,HU+7[$*+^75MWN/NA[UI.?\*P_C7@\1NCX
MS?++!8U*3+;QI=R])]B5D%.8XLE4;:A@W7US65,D2"*7*?PVNSE,\DI\KTM)
M3HI*063)GV"WJ62"^V"5JQQE9HQ7AJ[) /E4(<8J2>)ZQO\ ?79XHY[+?8EI
M)(&AD/KI[HR?G0N,YH . Z2O_"3SY#93%=R?)7XLY#(.^W=Z=?8OO#;./G=1
M3T&Y]BYW$;+W.V/%U)K=QX/>F/:=3J+185"ND(VI1[^[/')MMEOJ#]:*8P,?
M574NM?DK(U/FY]>F/8K=GCW&\V-S^C)$)E'HR,$:GS976OR0=7#_ /"F3_MU
MSNK_ ,31T_\ ^[?(>XZ]D_\ E>H_^>:;_ .I!]Y?^5)D_P">F+_">M2S_A/;
M_P!O?OB+_P"5\_\ @8>ZO>0'N]_T[O</^;'_ &DP]0/[3_\ *_V'_-__ +1I
MNOIL^\(^LSNJE/YZW_;ISYD?^&9LG_W[G7ON0/:S_E?]M_YJO_U:DZ ?N=_R
MHFX_\TT_ZNQ]:2/_  GM_P"WOWQ%_P#*^?\ P,/=7O)SW>_Z=WN'_-C_ +28
M>L;?:?\ Y7^P_P";_P#VC3=?0]^;'_9&?RW_ /%8^^O_ 'U>Z_>'_+/_ "LF
MW_\ /=!_U=3K+3F3_E7;_P#YXI_^K3=?*+^.'_90_0W_ (F?J[_WN,'[SWWG
M_DCW?_/-+_QQNL&-G_Y*UK_STQ_\?7K["'OG9UT!ZU_?^%+?6>U-Z?RP-[;U
MS5'CVW'T_P!G=4[MV9D)T1,C3UVX]X8[KG,T&/J!"\S05^"WC-+/3ZTBD^U2
M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
M\:WFB9#YU9Q&0/M5R2.& ?(=:KO_  G#WEF]L?S8NCL)BC4"A[%V5W=LW<OA
MD*1G"4/4VZ^P8!5J(91+3_WCV+CR%+1CRA&U&VAIW]Y;:*?D"ZEDIKAEA=?]
M,94CQ\]+M^5>H/\ :"XD@Y[MHDKIFCF1OL$329_VR+^=.MX7Y&?R^*7M+N:@
M^1?3?9>-Z:[>.?Z_W7NZGW=UE1]S=1]A;QZEHZ[&=4]B[IZYDW=UYF:;M#K;
M$9.>@Q><Q.X,9.V.=:6M2LIX8(XL8-FYO:QVT[-N4#7.W:)$31*898TE(,L:
MR:)%,4A 9D>-AJ[E*DDG)7=^4UOMQ&[[=,+?<-<;-KC$T4CQ B*1H]<9$D8)
M57613I[6#  #/\3?Y>.V/CQVCO/Y [ZWS%VUWGO.HWK)3Y+";'H>J.HNMH.R
M<_0;I[*/4?3V/SV[8MIYCLW<6*I*S<65K<QE\IDI*6-1/%$9HY=;_P X3[Q8
MQ;1:Q?3[7$$PSF663PU*Q^+,536(E)$:JB*M3@FA&]AY2AVF^DW6ZE^HW.0O
MD((HH_$8-)X409])D8 R,79FH,@5!L8]@WH7]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U\\'_A49_P!O*L%_XK)U;_[UG9GO,#V+_P"5*?\ Y[I?
M^.1=8E^]G_*XK_SQ1?\ 'I.K:?\ A)=_V3Q\MO\ Q,^R/_>'G]Q_]X#_ )+&
MW_\ /,__ !_H>>P__))O_P#GI3_CG6VK[Q_ZGCJI3^>M_P!NG/F1_P"&9LG_
M -^YU[[D#VL_Y7_;?^:K_P#5J3H!^YW_ "HFX_\ --/^KL?6A3_)G_[>C?"C
M_P 31B__ '49CWE=[D?\J+N?_/,?\(ZQ<]N_^5VVW_GI'^ ]?5!]X(]9O]?+
MR_GJ_P#;V+YD_P#AZ;+_ /?2]?>\Y?:S_E0-M_YI/_U=DZPI]SO^5[W'_FHG
M_5J/K;N^>'PL'S1_D;=+8?;V)&1[8Z6^+W1/=_5!A@:;(UF7V7TW@9=T;5HE
MA*3U,N\MD39"CIZ>_CDR9HY&4F);8]<J\R_U:]T;F29M.WW-]/!+Z /,VESZ
M:'TDG^'4//J?.:.7/ZQ^V=M'$M;ZVLH)HO4E(5U*/].FH ?Q:3Y=:R?_  G<
M^:S?%7YY;?ZVW/E6H^J/E;3X_I[<L514F''8WL&2N>HZ@W/)$2L<E7'N:JEP
M09V6.&EW#/*US&ON;O>'EG]_<J/>P+6_L"9EQDQT_67[-(#_ #,8'GU#'M)S
M)^X^:$LYFI8WP$3>@DK^DWVZCH^0D)\NKMO^%:/_ &3Q\2?_ !,^]_\ WAX/
M<8_=_P#^2QN'_/,G_'^I)]^/^238?\]+_P#'.D7_ ,)'_P#F7GS?_P##SZ+_
M /='V?[4_>"_W,VO_FE/_P >BZ3>PO\ N)N7_-2'_CLG6X3[QVZR!Z^-WV/_
M ,S#WY_X>>Z/_=Y7>^CEE_N'%_S27_CHZYZWG^Y<O_-1O^/'KZNO\N#_ +=X
M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
M'%ZY_;Q_R5KK_GID_P"/MU:;TE_PG[_F)_('J+KCN[KK;75%3L3M79^#WSM*
MHRW:.+Q>3FP&X:&+(8V2NQTM$\E%5-33*7C8DH>/8$W/W;Y.VC<)MLO'N!=0
M2,CTB)&I30T-<BOGT-]M]J>;MUL(=RM$@-K/&KK60 Z6%144P>A1_P"@9S^:
M/_SRG3'_ *.##_\ U![0_P"O9R+_ +\N?^<)_P _2W_6:YV_WW;?\Y1_FZ(Y
M\X?Y4_RX_EZ[5V-O+Y'8?8N,PG8>X,CMG;<FTM[46ZJB7*8O'+E:M*NGI::!
MJ2$4C JY)#-Q[%'*_/O+W-\\MMLS2M+"@9M:%<$T%*\<]!KF7D;?N4X(KC>%
MB6.9RJZ7#9 J:TX8ZM+_ .$I7_;P[N7_ ,4P[#_]_A\=?8$]^_\ E3[;_I91
M_P#5BXZ&WL9_RMMQ_P!*Z3_J];]?0*]XD=96=?&(]])>N=O5PFV_Y^/\V;:.
MW<!M3;WRO_A^ VQA<7M[!T'^@KXUU?V.'PM#!C<91_=5W3E36U/VU%3(GDFD
MDE?3=V9B28ZF]I^0+B9[B:PK,[%F/CW(J6-2:"8 5)\A3J0(?=+GNWA2"&^I
M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
MPDM$4.+/76^*+(8JC19#4QT-'23L09D)S(]MN8UYKY1@FN2'O85\"<'-60 :
MFKQ\1"K'%-18>76(?N)R\W*_-<T-N"EG*?&A(Q17).D4X>&X91YT"GSZLM_G
M$?,>B^=7\IS^7!WO+74]3OF3LS>NQ^WZ2 )&^-[9V5L*AQ6[S+31 1T<6XF$
M&;I(06\>/RE.";W !7MSRXW*W/\ O.U $6O@(\)]8GD)3/GIRA/\2GH9>X/,
M*\S\B;/NA(-SXSI*/25$ ?[-6' _A8='3_X2/_\ ,O/F_P#^'GT7_P"Z/L_V
M&?O!?[F;7_S2G_X]%T(_87_<3<O^:D/_ !V3K<)]X[=9 ]?&[['_ .9A[\_\
M//='_N\KO?1RR_W#B_YI+_QT=<];S_<N7_FHW_'CU]77^7!_V[Q^!G_BF'Q<
M_P#?'[&]X$<Y_P#*X;M_TLKK_J^_6=')_P#RJ6U_]*ZV_P"K*='/]AKH1=:8
M?_"N[_NGQ_Y=A_\ .U>\D_N]?\M?_J%_[6>L=O?S_ED_]17_ &K]%D_X2>?]
MEF?(W_Q6.?\ ]^IUY[._?W_E6[/_ )[O^L4G1+[%?\K%>?\ /%_UECZWU_>*
M/64?0+_)#_LG?OK_ ,0OVE_[P^=]F>R_\EBT_P">F+_CZ]%V\?\ ))NO^>:7
M_CC=?'P]]$NN?W7V=_?-KKHEU[W[KW7O?NO=?/U_X5:_]O#NFO\ Q3#KS_W^
M'R*]Y;^PG_*GW/\ TLI/^K%OUBG[Y_\ *VV__2NC_P"KUQU;3_PD\_[(U^1W
M_BS<W_OJ^OO<?^_O_*R6?_/#_P!99.A[[%?\J[>?\]O_ %BCZVH?<$=3?U1O
M_P *+.V,-UG_ "K.[<'7U-+#F>X]S]6]5[4@J7YK<K/OS"[[S$4$0LTTT.R]
MB965;$!#&'-PNEI1]G=ODO>?+65 3';)+*_R'AE!_P ;=1U&?NY?QV7(]S$Q
M'B7#Q1+\SK#G_C",>M*W^1]UED.U/YIOQ!Q%%3O-!M?L&M[-RDX\@BH<?UAM
M?.[X6HJ'C>,QI-D<)3TZ7.EIIT0A@VDY+>Z%\EAR)N,C',D(B'S,K*G^!B?L
M!ZQR]M;)[[G?;XU&$E,A^0C5G_PJ!]I'7U&O>#'6;/7Q[_D?_P!E#]\_^)G[
M1_\ >XSGOHGLW_)'M/\ GFB_XXO7/[>/^2M=?\],G_'VZ^H;_*C_ .W:OP:_
M\5DZE_\ >3Q_O!KGW_E==T_Y[I?^/GK-;D7_ )4[;/\ GBB_XZ.K _81Z%?6
MI5_PK1_[)X^)/_B9][_^\/![R ^[_P#\EC</^>9/^/\ 4#^_'_))L/\ GI?_
M (YU65_PE*_[>'=R_P#BF'8?_O\ #XZ^QO[]_P#*GVW_ $LH_P#JQ<= OV,_
MY6VX_P"E=)_U>M^OH%>\2.LK.OC$>^DO7.WK[!_QO_[)WZ%_\0OU;_[P^"]\
M[=Z_Y+%W_P ],O\ Q]NN@.S_ /))M?\ GFB_XXO0T>RSHQZ][]U[HA_\SCY+
M1_$;X'?)GO*#(?PW<>W^M<M@-@5$<ZPU2]D;]:'8VP9Z1;&6H?&;IW#35LJ1
MC4*:FE>Z*K.HJY(V4\P\UV.UD:H7G#2>GAQ]\E?M52!\R/LZ"_.F\C8.5[W<
MP:3)"53U\1^Q*?8S GY ]?,!^)/>V.^,'R4Z8^0V2Z^H>TDZ:WSB^P<=L;)9
MN7;M%EMQ;<\M?M6JES,&,S,U$<#N:.DR*%::0N]($].K4N<?,&U/OFRW.SI,
M8#<Q&,N%U$*V&&FHKJ6J\1QZPKV'=$V7>;;=GB$_T\HD"$Z067*FM#32U&X>
M76S]_P!!<'8G_>$.R_\ T>><_P#M9>X._P"!]L_^CI+_ ,X%_P"MO4U?Z_5W
M_P!&V/\ YS-_UKZU?_EIWKC_ )._)3N?Y#8[8%%U>O<N^LOV'D=D8_-/N*CQ
M&X=RM'D=TSPYF7%822N_C>Y9JNO8M31LC510ERNMIQY?VI]CV6VV=YC/]-$(
MPY722JX7%6II6B\?+RX=0KOVYIO6\7.[)$(/J)3(4!U ,V6S05JU6X>?Y];S
M?_"7WY-KVU\%MS= Y:O6?<_Q=[&R&*H:5YQ-4KUKVG/D]\;3JIB]IP!NX;EH
MXU.I(Z>CB56L B8N>^6Q_N_FE-VC%(+Z$$GR\2*B./\ >/#/VD_:<F?97>OK
M^6'VJ0UGLIB /^%RU=3_ +WX@^P#[!8]_.9_[=<?-?\ \0QDO_=QAO8,]MO^
M5ZVS_GI'^ ]"_P!Q/^5)W+_GF/\ A'7S6OA1_P!EE?$G_P 6;Z%_]^IM3WFE
MS-_RK>X?\\,__5I^L.N6_P#E8K#_ )[8/^KJ]?7<]\]NL^>O>_=>Z][]U[KY
MX/\ PJ,_[>58+_Q63JW_ -ZSLSWF![%_\J4__/=+_P <BZQ+][/^5Q7_ )XH
MO^/2=7._\)//^R-?D=_XLW-_[ZOK[W&WO[_RLEG_ ,\/_663J1?8K_E7;S_G
MM_ZQ1];4/N".IOZ)A_,?_P"W>/SS_P#%,/E'_P"^/WS[$O)G_*X;3_TLK7_J
M^G0=YP_Y5+=/^E=<_P#5E^OE=_'6..;Y!=%0S1I+%+W)UC'+%(BR1R1R;VP:
MO'(C JZ.I(((((/O.[>"1M%T1Q^FE_XXW6#^T '=K4'A]1'_ ,?7KZ[_ /HW
MZ[_YX+9?_H+8/_ZA]\]?K;S_ '[+_O3?Y^L^?H[3_?4?^\K_ )ND;V-USUZG
M7N^W38FS4=-F[H967:^$5E9<)7%65A0@A@1<$?3VIL[R\^LB_5D_M%_$W\0^
M?2>[M+06DOZ4?]FWX1Z'Y=?'N]]$^N?W7V0^M_\ F7>PO_#+VM_[HZ'WSCO?
M]S)?^:K?\>/70FS_ -Q(O^::_P#'1TM/:;I3UII?\*UNG,E-C/AW\@:&CE?$
M8^N[+Z<W1D-4IAILEF*? ;UV)1A=1A66NI<'N-R0%9A3BY8 :<D/N_;B@?<=
MH8_J$1S*/4#4DA_(M'^WK'CWXV]RFW[JH_3!DB8_,Z70?F%D_9U35_PGL[\P
M_0_\S_IN/<60BQ6 [JPF[NAZZNGD6.%,IOBDI<ELFC?78,V8[$VUB*%!<6DJ
M5/XL9']WMIDW7D>Y,(U36S).!\D)#G\HV=ORZCSVGW6/:^=;<3'3%<J\!/S<
M H/SD5%_/KZ87O"CK,KKWOW7NOC=]C_\S#WY_P"'GNC_ -WE=[Z.67^X<7_-
M)?\ CHZYZWG^Y<O_ #4;_CQZ^M1\)_\ LC/XD?\ BL?0O_OJ]J>^?_,W_*R;
MA_SW3_\ 5U^L\.6_^5=L/^>*#_JTO6A3_P *8_\ MZ/NO_Q#'3__ +IZ_P!Y
M7>R?_*BQ_P#/3-_A'6+GO+_RNTG_ #S1?X#U>C_PD\_[(U^1W_BS<W_OJ^OO
M<6>_O_*R6?\ SP_]99.I.]BO^5=O/^>W_K%'U2!_PHR^!47Q2^8S=X;#PS4/
M3GRP;.;\IDI8=..VWV_1U<,G:6W8Q&K)24^:JLG39^E#E [Y.JA@0149M)_L
MWS6=_P"7/W7=M7<=OTQFO%H2/TF^>D QG_2J2:MU&GN[RL-BYA_>=JM-OOZN
M*<%E!_57Y5)#C_3,!A>KU/\ A,G\_3W=\>\]\+^PLU+5]F?&VD&8ZWEKYUDJ
M<_T-E:^&EI<= [R2553+UAN>M^P<MIC@Q>2Q<$0(A?3%GO=RE^[-W3F6S6EE
M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>unh-20210715_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="unh-20210715.xsd" xlink:type="simple"/>
    <context id="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-07-15</startDate>
            <endDate>2021-07-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl80L2ZyYWc6OWJiZTJhMWY2Y2ZlNGMyMmE3MGFjNTVjMzZiMTJmMTYvdGFibGU6YTI5OTRjMDIxOWUwNGNiYjkwOGZmMWI1ZDMxZDgwZDQvdGFibGVyYW5nZTphMjk5NGMwMjE5ZTA0Y2JiOTA4ZmYxYjVkMzFkODBkNF8yLTEtMS0xLTA_d33128df-4933-4bbd-b098-20a13afafa04">0000731766</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl80L2ZyYWc6OWJiZTJhMWY2Y2ZlNGMyMmE3MGFjNTVjMzZiMTJmMTYvdGFibGU6YTI5OTRjMDIxOWUwNGNiYjkwOGZmMWI1ZDMxZDgwZDQvdGFibGVyYW5nZTphMjk5NGMwMjE5ZTA0Y2JiOTA4ZmYxYjVkMzFkODBkNF8zLTEtMS0xLTA_22b60b04-8a99-40d7-9a44-a8695d1ff03c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjkw_4821a4b9-9b32-4ff7-a679-5bfdf5bd68ec">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8yNTc_5387ed7c-75bf-4418-ae5b-d3c1382d6fe9">2021-07-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjkx_a2123d33-9f64-46e4-a953-8861d5294a8f">UNITEDHEALTH GROUP INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTAtMS0xLTA_3ccd6147-4483-4583-b4ef-42f3b5289f7a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTItMS0xLTA_baba399b-4771-446f-9cd0-9266207fdbd8">1-10864</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6ZmZhMjAwYzgyMDlhNDdmNmFlNmQ0MTNmZmU2Mzk0NzcvdGFibGVyYW5nZTpmZmEyMDBjODIwOWE0N2Y2YWU2ZDQxM2ZmZTYzOTQ3N18wLTQtMS0xLTA_2fcfb111-a20c-45ee-a48e-24cdc39a3b98">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTAtMS0xLTA_716864a6-3515-4af4-863f-dcc8ab948ee3">UnitedHealth Group Center, 9900 Bren Road East,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTEtMS0xLTA_3f174e48-fc80-4e35-b063-35281af40d93">Minnetonka,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTItMS0xLTA_caac745f-c73f-4513-baaa-a0df6050f656">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6NzQwMzlmMmU4YTNiNDVmZmFjMTEyZTg3MmYyNWRlOWYvdGFibGVyYW5nZTo3NDAzOWYyZThhM2I0NWZmYWMxMTJlODcyZjI1ZGU5Zl8wLTMtMS0xLTA_55ea7bb1-d5c7-4a7f-aaaf-715bc3ce7d46">55343</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjky_e6460718-bd3f-47ee-9f63-208b5e2bc4a1">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg0_0ab30729-a297-4a57-9a92-cb46660f1277">936-1300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg1_48aa3e0e-5ee0-4c93-aa94-fb6880662e9a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg2_d9a7603b-bfd2-47db-9d37-02959815e74d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg3_e999fed9-eb75-480a-9a83-a6c74b66f741">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg4_da48ba91-f295-45cf-847b-32387c550ce6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTAtMS0xLTA_0008709e-4f1b-42a9-a50d-63cbcd3061c7">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTItMS0xLTA_90c7803e-4063-4367-bebe-7f605f4747c1">UNH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGFibGU6MmVlODE4MTU5Yjk0NGFjNWFmZmU1Y2Q1N2JkMmIzZTUvdGFibGVyYW5nZToyZWU4MTgxNTliOTQ0YWM1YWZmZTVjZDU3YmQyYjNlNV8xLTQtMS0xLTA_78e4b9ba-fa40-4b6d-8aec-8a6fb02070e1">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715"
      id="id3VybDovL2RvY3MudjEvZG9jOmJmOTI2NjI2NjFhZDQzMWNiMDNjYmM1ODgwNGNkYmMyL3NlYzpiZjkyNjYyNjYxYWQ0MzFjYjAzY2JjNTg4MDRjZGJjMl8xL2ZyYWc6Zjc5OGJjMDRhM2E2NDVhOGEwMGQxODYwNzFmNmFmODIvdGV4dHJlZ2lvbjpmNzk4YmMwNGEzYTY0NWE4YTAwZDE4NjA3MWY2YWY4Ml8xNjg5_926119c9-9cf8-4f2b-a29b-03b3f4350f85">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140717028328312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 15,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UNITEDHEALTH GROUP INCORPORATED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-10864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1321939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">UnitedHealth Group Center, 9900 Bren Road East,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minnetonka,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">936-1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UNH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000731766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " ![,.]2!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( 'LP[U*+1U5_
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( 'LP[U*97)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ >S#O4I]H&P=-!   6A
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( 'LP[U*?H!OPL0(  .(,   -              "  9$,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ >S#O4I>*NQS     $P(   L
M         ( !;0\  %]R96QS+RYR96QS4$L! A0#%     @ >S#O4JK$(A8S
M 0  (@(   \              ( !5A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( 'LP[U(D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( 'LP[U)ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="unh-20210715.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.unitedhealthgroup.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="unh-20210715.htm">unh-20210715.htm</File>
    <File>a2021q2exhibit991.htm</File>
    <File>unh-20210715.xsd</File>
    <File>unh-20210715_def.xml</File>
    <File>unh-20210715_lab.xml</File>
    <File>unh-20210715_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "unh-20210715.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "unh-20210715_def.xml"
     ]
    },
    "inline": {
     "local": [
      "unh-20210715.htm"
     ]
    },
    "labelLink": {
     "local": [
      "unh-20210715_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "unh-20210715_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "unh-20210715.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "unh",
   "nsuri": "http://www.unitedhealthgroup.com/20210715",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20210715.htm",
      "contextRef": "i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.unitedhealthgroup.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20210715.htm",
      "contextRef": "i90e8dede517248ea8c48a6eb2fed7c93_D20210715-20210715",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000731766-21-000033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000731766-21-000033-xbrl.zip
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M ;W+&9@S'$C0ST'R,!2)E9'(Q'*'@]"+-S@9MI&2I5K&\%2X$N7:LV&U)Z,
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M^R.P.7/^G43[78?>S5<M+X#]5%+!->O-(CFZ2XIBLZX5Z>"JI"B"$E4EC/N
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M,0XB-X;W? BI9\?N(YT>&Z&C/'.7.'12I[?8/=BZ)?'J6Y:=?KV*&#&DK5D
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M@=O+L+E6O3O^_0.A\M]<#F["?-_U&-1NP8RSP?3]F&[,,6T1B\BF:6%%UT4
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MU/HKR#YXMN;_ O9_">.30%\N'D4%)Z8OKU[<7>[^= ^GO7KQ7U!+ P04
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MYFZEVN:(HTEW;T*[^MT_\"![X0O*M $6#$+J$]TI@@".!0$$4@F\B'.B5MY
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MUP1_5W*-O[<UQF<IS_+K+"^]=MFV=IK=I$5^O]8@H[$O7!=$NMT4$Z8>,21
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MMTI4(D^M)&S .6MT_<5?I:M;Z=8D'%G6/?,W$G!CKE9JK48:39J-">SJL'F
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MD;,90_9-/74.AK?T[,1\GH:>>E*M[3P-0P<*_$NV*NCBO\EUV:/JBIA!AEP
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M%W<_="_=GQU?O_@?4$L! A0#%     @ >S#O4D<+M%X^.P  L7H# !4
M         ( !     &$R,#(Q<3)E>&AI8FET.3DQ+FAT;5!+ 0(4 Q0    (
M 'LP[U*9O3#O&Q0  #66   0              "  7$[  !U;F@M,C R,3 W
M,34N:'1M4$L! A0#%     @ >S#O4L*><[!\ @  @P@  !
M ( !ND\  '5N:"TR,#(Q,#<Q-2YX<V102P$"% ,4    " ![,.]2O..GJ>D'
M  "5.   %               @ %D4@  =6YH+3(P,C$P-S$U7V1E9BYX;6Q0
M2P$"% ,4    " ![,.]2])AS\[D+  #*;   %               @ %_6@
M=6YH+3(P,C$P-S$U7VQA8BYX;6Q02P$"% ,4    " ![,.]2%;_&X7H'  "Z
M.@  %               @ %J9@  =6YH+3(P,C$P-S$U7W!R92YX;6Q02P4&
2      8 !@"% 0  %FX

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
